The presentation discusses various treatment options and operations for managing thalassemia. It highlights the results of emerging therapies such as mitapivat and luspatercept. Additionally, it includes mentions of gene therapy and transplantation. These treatments collectively aim to manage symptoms, reduce complications, and improve the quality of life for patients with thalassemia.
Login to view comments.
Click here to Login
